Ashland Inc. (ASH)

NYSE: ASH · Real-Time Price · USD
76.21
-0.18 (-0.24%)
Nov 20, 2024, 4:00 PM EST - Market closed
-0.24%
Market Cap 3.59B
Revenue (ttm) 2.11B
Net Income (ttm) 169.00M
Shares Out 47.11M
EPS (ttm) 3.35
PE Ratio 22.75
Forward PE 16.72
Dividend $1.62 (2.13%)
Ex-Dividend Date Aug 30, 2024
Volume 331,571
Open 75.89
Previous Close 76.39
Day's Range 75.04 - 76.25
52-Week Range 75.04 - 102.50
Beta 0.88
Analysts Buy
Price Target 102.50 (+34.5%)
Earnings Date Nov 6, 2024

About ASH

Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; and nutraceutical solutions comprising products for weight m... [Read more]

Sector Materials
Founded 1924
Employees 3,800
Stock Exchange NYSE
Ticker Symbol ASH
Full Company Profile

Financial Performance

In 2024, Ashland's revenue was $2.11 billion, a decrease of -3.56% compared to the previous year's $2.19 billion. Earnings were $169.00 million, a decrease of -5.06%.

Financial Statements

Analyst Forecast

According to 7 analysts, the average rating for ASH stock is "Buy." The 12-month stock price forecast is $102.5, which is an increase of 34.50% from the latest price.

Price Target
$102.5
(34.50% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Ashland board authorizes quarterly dividend

WILMINGTON, Del., Nov. 14, 2024 (GLOBE NEWSWIRE) -- The board of directors of Ashland Inc. (NYSE: ASH) has declared a quarterly cash dividend of $0.405 cents per share on the company's common stock. T...

6 days ago - GlobeNewsWire

Ashland Inc. (ASH) Q4 2024 Earnings Call Transcript

Ashland Inc. (NYSE:ASH) Q4 2024 Earnings Conference Call November 7, 2024 8:00 AM ET Company Participants William Whitaker - VP, Finance and Director, IR Guillermo Novo - Chair and CEO Kevin Willis -...

11 days ago - Seeking Alpha

Top 3 Materials Stocks That Are Preparing To Pump In Q4

The most oversold stocks in the materials sector presents an opportunity to buy into undervalued companies.

Other symbols: CEMATV
12 days ago - Benzinga

Ashland to host live 2024 strategy update event for analysts and investors

WILMINGTON, Del., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) will host a strategy update event for analysts and investors on Tuesday, December 10, 2024, in New York City. The company w...

12 days ago - GlobeNewsWire

Ashland sets date for fourth-quarter fiscal 2024 earnings release and conference call webcast

WILMINGTON, Del., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced plans to issue its fourth-quarter fiscal 2024 earnings release at approximately 5 p.m. ET on Wednesday, Nov...

23 days ago - GlobeNewsWire

D.A. Davidson Acts as Exclusive Financial Advisor to Turnspire Capital Partners for Debt Financing in Support of Turnspire's Acquisition of Pharmachem

NEW YORK--(BUSINESS WIRE)--D.A. Davidson & Co. announced today that it served as exclusive financial advisor to Turnspire Capital Partners LLC (“Turnspire”) on an asset-backed credit facility to finan...

2 months ago - Business Wire

Ashland completes sale of nutraceuticals business

WILMINGTON, Del., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced it has completed the sale of its nutraceuticals business to an affiliate of Turnspire Capital Partners LLC...

2 months ago - GlobeNewsWire

Pharmachem Innovations Launches as a Leading Independent Provider of Nutraceuticals Products and Solutions

KEARNY, N.J.--(BUSINESS WIRE)--Pharmachem Innovations, LLC (“Pharmachem” or the “Company”), a leading provider of nutraceuticals products and solutions, today announced its launch as an independent co...

2 months ago - Business Wire

Turnspire Capital Partners Completes Acquisition of Pharmachem from Ashland

NEW YORK--(BUSINESS WIRE)--Turnspire Capital Partners LLC (“Turnspire”) announced today that an affiliate has completed the acquisition of Pharmachem Innovations, LLC (“Pharmachem” or the “Company”), ...

2 months ago - Business Wire

Ashland Inc. (ASH) Q3 2024 Earnings Call Transcript

Ashland Inc. (NYSE:ASH) Q3 2024 Earnings Conference Call August 7, 2024 10:00 AM ET Company Participants William Whitaker - Vice President-Finance and Director-Investor Relations Guillermo Novo - Cha...

3 months ago - Seeking Alpha

Ashland reports financial results1 for third quarter fiscal 2024, issues outlook for fourth quarter and full-year fiscal 2024

WILMINGTON, Del., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced financial results1 for the third quarter of fiscal year 2024, which ended June 30, 2024, and issued its out...

3 months ago - GlobeNewsWire

Ashland sets date for fiscal 2024 third-quarter earnings release and conference call webcast

WILMINGTON, Del., July 17, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced plans to issue its third-quarter earnings release at approximately 5 p.m. ET on Tuesday, August 6, 2024. Th...

4 months ago - GlobeNewsWire

Ashland achieves certification by Fair Wage Network

WILMINGTON, Del., June 18, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) has strengthened its performance  towards environmental, social and governance (ESG) practices and a more just and equitable...

5 months ago - GlobeNewsWire

13 Upcoming Dividend Increases

Thirteen dividend increases are featured, with RLI Corp leading the charge with a 49-year streak and a potential to become a dividend king next year. The list is created by merging data from the "U.S....

Other symbols: ACNBCBTDEEVRFDSHBBHY
6 months ago - Seeking Alpha

Ashland Board appoints Ashish K. Kulkarni as new director

WILMINGTON, Del., May 08, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) is announcing the appointment of Ashish K. Kulkarni to its Board of Directors. Kulkarni is the CEO of Kebotix, a startup com...

7 months ago - GlobeNewsWire

Turnspire Capital Partners to Acquire Ashland Nutraceuticals Business

NEW YORK--(BUSINESS WIRE)--Turnspire Capital Partners LLC (“Turnspire”) announced today that an affiliate has signed a definitive agreement to acquire the nutraceuticals business of Ashland Inc. (NYSE...

7 months ago - Business Wire

Ashland signs definitive agreement to sell nutraceuticals business to Turnspire Capital Partners

WILMINGTON, Del., May 07, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) announced today that it has signed a definitive agreement to sell its nutraceuticals business to Turnspire Capital Partners ...

7 months ago - GlobeNewsWire

Ashland Inc. (ASH) Q2 2024 Earnings Call Transcript

Ashland Inc. (NYSE:ASH) Q2 2024 Results Conference Call May 1, 2024 9:00 AM ET Company Participants William Whitaker - Vice President of Finance and Director of Investor Relations Guillermo Novo - Ch...

7 months ago - Seeking Alpha

Ashland reports financial results1 for second quarter fiscal 2024; issues outlook for third quarter and full-year fiscal 2024

WILMINGTON, Del., April 30, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced financial results1 for the second quarter of fiscal year 2024, which ended March 31, 2024, and issued its ...

7 months ago - GlobeNewsWire

Ashland sets date for fiscal 2024 second-quarter earnings release and conference call webcast

WILMINGTON, Del., April 18, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced plans to issue its second-quarter earnings release at approximately 5 p.m. ET on Tuesday, April 30, 2024. ...

7 months ago - GlobeNewsWire

Ashland Board appoints Scott A. Tozier as new director

Tozier is strategic advisor to the CEO, and former executive vice president and chief financial officer of Albemarle Corporation Tozier is strategic advisor to the CEO, and former executive vice presi...

7 months ago - GlobeNewsWire

Ashland announces executive organization changes to personal care and specialty additives

WILMINGTON, Del. , April 03, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH), the global additives and specialty ingredients company today announced executive organization changes to its personal ca...

8 months ago - GlobeNewsWire

Ashland Inc. (ASH) Q1 2024 Earnings Call Transcript

Ashland Inc. (ASH) Q1 2024 Earnings Call Transcript

10 months ago - Seeking Alpha

Ashland reports financial results1 for first quarter fiscal 2024; issues outlook for second quarter and full-year fiscal 2024

Sales of $473 million, down 10 percent from the prior-year quarter Net income (including discontinued operations) of $26 million, or $0.51 per diluted share Income from continuing operations of $28 mi...

10 months ago - GlobeNewsWire

Ashland sets date for fiscal 2024 first-quarter earnings release and conference call webcast

WILMINGTON, Del., Jan. 16, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced plans to issue its first-quarter earnings release at approximately 5 p.m. ET on Tuesday, January 30, 2024. ...

11 months ago - GlobeNewsWire